PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-23.1 - CONSENT - March 8, 2018

Attached files

file filename
EX-32.1 - 906 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh32-1.htm
EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-2.htm
EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-1.htm
EX-21.1 - SUBSIDIARIES - PERNIX THERAPEUTICS HOLDINGS, INC.exh21-1.htm
EX-10.43 - WAIVER, AMENDMENT AND CONSENT AGREEMENT, DATED NOVEMBER 2, 2017, AMONG PERNIX TH - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-43.htm
EX-10.42 - OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-42.htm
EX-10.41 - OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-41.htm
EX-3.2 - BYLAWS - PERNIX THERAPEUTICS HOLDINGS, INC.exh3-2.htm
10-K - 10-K - PERNIX THERAPEUTICS HOLDINGS, INC.body10k.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-168877, No. 333-167327, No. 333-166062, No. 333-175992, No. 333-204997, No. 333-210852, and No. 333-221678), Form S-4 (No. 333-200042) and Forms S-3 (No. 333-186048, No. 333-174629, No. 333-200011, No. 333-219420, No. 333-221717) of Pernix Therapeutics Holdings, Inc. of our report dated March 8, 2018 relating to the consolidated balance sheets of the Company as of December 31, 2017 and 2016, and the related consolidated statements of operations, comprehensive loss, stockholders' equity, and cash flows and the related consolidated statement schedule for each of the two years in the period ending December 31, 2017.

/s/ Cherry Bekaert LLP

Atlanta, Georgia
March 8, 2018

 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports